Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Hematopoietic stem cell transplantation is an important therapeutic approach for hematologic malignancies, and the impact of donor age on transplant outcomes remains an active area of investigation. Older donors may be associated with impaired stem cell fitness, delayed immune reconstitution, and reduced T-cell function. However, randomized controlled trials directly comparing transplant outcomes by donor age are difficult to conduct because of ethical constraints, and previous retrospective studies have yielded inconsistent findings due to confounding bias and limited causal interpretability. Target trial emulation (TTE) is a methodological framework that uses observational data to emulate the design principles of a randomized trial, thereby reducing biases such as immortal time bias, time-varying confounding, and prevalent-user bias, and improving the validity of causal inference. Therefore, this study will use a large single-center retrospective clinical cohort to perform a TTE analysis, aiming to approximate the causal framework of an randomized trial and systematically evaluate the effect of donor age on clinical outcomes after allo-HSCT, thereby providing higher-quality evidence to optimize donor selection strategies.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Younger Donor Group | Patients who underwent allogeneic hematopoietic stem cell transplantation with donors younger than 50 years. Grouping was based on donor age recorded in retrospective clinical data. | ||
| Older Donor Group | Patients who underwent allogeneic hematopoietic stem cell transplantation with donors aged 50 years or older. Grouping was based on donor age recorded in retrospective clinical data. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Overall Survival | Overall survival was defined as the interval between hematopoietic stem cell transplantation and death from any cause. | From the date of transplantation to the date of death from any cause or last follow-up, assessed up to 15 years. |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
This study includes adult patients with hematologic malignancies who underwent allogeneic hematopoietic stem cell transplantation at the study center. Eligible patients will be identified from retrospective clinical records and grouped according to donor age recorded at the time of transplantation.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Yang Xu | Contact | +86-512-67781850 | xuyang1020@126.com |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| The First Affiliated Hospital of Soochow University | Suzhou | Jiangsu | 215000 | China |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided